Cargando…
Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study
The microbiota has been observed altered in autoimmune diseases, including idiopathic inflammatory myopathies (IIMs), and associated with different treatments. Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestin...
Autores principales: | Zhufeng, Yunzhi, Xu, Jun, Miao, Miao, Wang, Yifan, Li, Yimin, Huang, Bo, Guo, Yixue, Tian, Jiayi, Sun, Xiaolin, Li, Jing, Lu, Dan, Li, Zhanguo, Li, Yuhui, He, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964112/ https://www.ncbi.nlm.nih.gov/pubmed/35360108 http://dx.doi.org/10.3389/fcimb.2022.757099 |
Ejemplares similares
-
Therapeutic potential of targeting Tfr/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study
por: Miao, Miao, et al.
Publicado: (2021) -
Hypomyopathic Dermatomyositis with Refractory Dermatitis Treated by Low-dose IL-2
por: Miao, Miao, et al.
Publicado: (2020) -
Dental Materials for Oral Microbiota Dysbiosis: An Update
por: Zhu, Jieyu, et al.
Publicado: (2022) -
Gut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With Preeclampsia
por: Wang, Jing, et al.
Publicado: (2019) -
Gastrointestinal Autonomic Neuropathy Exacerbates Gut Microbiota Dysbiosis in Adult Patients With Type 2 Diabetes Mellitus
por: Du, Yuhui, et al.
Publicado: (2022)